OCT-598

· Oscotec Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OCT-598, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors [Phase 1]